[16] [17] Semaglutide (as Wegovy) is further indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with obesity (initial BMI 30 kg/m 2 ) or who are overweight (initial BMI 27 kg/m 2 ) and have at least one weight-related comorbidity such as dysglycemia (prediabetes or type 2 diabetes), hypertension, dyslipidemia, or cardiovascular disease
The key to preventing muscle loss on semaglutide and IF lies in a combination of strength training and adequate daily protein and energy intake
I focus on triage: identify whether the source is metabolic, gastric, or oral, then target the weakest link
Neither is a stimulant or a traditional diet pill
If you would like to discuss any of this information further, please book a consultation with our nurse available either in person or online